Partner Investment Management’s Allena Pharmaceuticals ALNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$776K Hold
284,285
5.57% 3
2019
Q3
$1.12M Sell
284,285
-3,566
-1% -$15.3K 1.92% 19
2019
Q2
$1.17M Sell
287,851
-9,110
-3% -$49.8K 1.24% 29
2019
Q1
$2.08M Sell
296,961
-4,928
-2% -$35.7K 2.41% 11
2018
Q4
$1.65M Hold
301,889
2.05% 16
2018
Q3
$3.24M Buy
301,889
+3,884
+1% +$42.7K 2.48% 6
2018
Q2
$3.88M Sell
298,005
-277,402
-48% -$4M 3.14% 4
2018
Q1
$5.7M Hold
575,407
6.15% 1
2017
Q4
$4.72M Buy
+575,407
New +$7.09M 5.44% 2

Other funds holding ALNA

Partner Investment Management's ALNA Position: Q4 2019 in Review

Partner Investment Management held its Allena Pharmaceuticals (ALNA) position steady in Q4 2019 at 284,285 shares worth $776K. The position accounts for 5.57% of the portfolio, ranked #3.

Partner Investment Management first reported a position in ALNA in Q4 2017 and has held it in 9 quarters since. The position peaked at $5.7M in Q1 2018. 26 funds tracked by Wall St. Rank hold ALNA as of Q4 2019.

  • Partner Investment Management held 284,285 shares of Allena Pharmaceuticals worth $776K as of Q4 2019.
  • Partner Investment Management left its Allena Pharmaceuticals share count unchanged in Q4 2019.
  • Allena Pharmaceuticals made up 5.57% of Partner Investment Management's portfolio in Q4 2019, its #3 holding.
  • Partner Investment Management first reported a position in Allena Pharmaceuticals in Q4 2017 and has held it in 9 quarters since.
  • Partner Investment Management's Allena Pharmaceuticals position peaked at $5.7M in Q1 2018.
  • 26 funds tracked by Wall St. Rank held Allena Pharmaceuticals as of Q4 2019.

Based on Partner Investment Management's 13F filing for Q4 2019, filed 14 Feb 2020.